Introduction
Kidney cancer is the 14 th most frequent cancer worldwide 1 with renal cell carcinoma the most common type. Incidence rates increased until the middle of the 1990s and then stabilized, but recent estimates suggest that in some countries incidence rates are still increasing . An inverse relationship has been found between occupational UVB exposure and renal cell carcinoma risk in men, which could be partly attributable to vitamin D status 5 . In this systematic review we assessed the evidence from prospective studies on vitamin D status and kidney cancer risk, examining potential sources of heterogeneity between studies.
Materials and Methods

Search Strategy and Study Selection
The search criteria and data extraction protocol used were those used in the WCRF/AICR Continuous Update Project (full protocol available at http://wcrf.org/sites/default/files/protocol_kidney_cancer.pdf). Two reviewers independently selected the articles and extracted the data for the most highly adjusted model reported in each paper for renal cell carcinoma or kidney cancer. Figure 1 illustrates the flow of articles through the selection process. Four articles were relevant for inclusion containing data on three cohort studies (Copenhagen City Heart Study (CCHS) , which included 8 nested case control studies (see Table 1 for details). A report from the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study (ATBC) 10 was excluded as this cohort was already included in the Pooling Project . Circulating 25(OH)D was assessed from serum or plasma samples in all studies except the NHS and HPFS 7 whereby 25(OH)D was predicted using validated regression models that included major determinants of vitamin D status.
FIGURE 1 ABOUT HERE
Data analysis
Study results were tabulated and shown in a forest plot. Summary estimates were not calculated due to the differences in the increment units and contrasts used in the studies.
Contrasts chosen for inclusion in the forest plot were those closest to the well-established 
Results
Study characteristics are shown in . However, this effect was not statistically significant when <25nmol/L (referent) was compared with ≥75nmol/L (Table 1) . However, there was no effect modification by sex in the EPIC study 8 , and in the cohorts with predicted circulating 25(OH)D scores (NHS and HPFS), similar inverse associations were observed in men and women. . Some differences between study results may be due to differences in study follow up times. For instance, the CCHS cohort had a relatively 
Discussion
Conclusion
There is no clear explanation for the inconsistent results seen in this review, but differences in study populations and specifically the prevalence of smoking might partially explain it. For instance, EPIC and the CCHS were in European populations, whereas the Pooling Project included populations from Asia, Europe and USA. This review is limited by the small number of studies in the review and the possibility of publication bias. Overall, the existing evidence does not rule out a possible beneficial effect of adequate vitamin D status against kidney cancer development. Note for figure 2: *Reference category changed so risk is for a 50% increase in 25(OH)D rather than a 50% decrease **Reference category was changed to <25nmol/L and the top two categories pooled to produce a cut-off point of =>75nmol/L ***ATBC; CLUE; CPS-II; MEC; NYU-WHS; PLCO; SMHS/SWHS **** Matched control data displayed here; combined control data gave a statistically significant effect (OR=0.82 (0.68, 0.99)). 
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